Hormone Therapy News

Among transgender adults who received gender-confirming care as adolescents, those living in transgender-supportive states are less likely to avoid health care than those who live in unsupportive states, according to study data.

Nonbinary youths report more depression and are more likely to attempt self-harm than binary transgender youths, according to study findings published in LGBT Health.

The prolonged use of certain progestogen hormone drugs — such as medrogestone, medroxyprogesterone acetate and promegestone — increased the risk for developing intracranial meningioma, according to data published in The BMJ.

Hormone therapy was associated with an improved weight-loss response for postmenopausal women with overweight or obesity treated with semaglutide, according to cohort study results published in Menopause.

In this video exclusive, Nicole Gomez, MD, talks with Caroline T. Nguyen, MD, about diagnosing and managing thyroid dysfunction in the postpartum period.

In this video exclusive, Caroline T. Nguyen, MD, talks with Cynthia A. Stuenkel, MD, MSCP, about diagnosing primary ovarian insufficiency, a condition similar to but different from menopause among women younger than 40 years.

Transgender girls see most of their body composition changes occur during puberty suppression, whereas transgender boys experience greater body composition changes during gender-confirming testosterone therapy, according to study data.

Menarche after the age of 14 years, or going through menopause before 45 years of age, are among the hormonal and reproductive factors that increase the risk for rheumatoid arthritis, according to data published in RMD Open.

According to published results, recombinant human growth hormone therapy was associated with increased risk for proximal tibial physeal avulsion fractures in pediatric patients.